UNSPSC 51292207: Itopride hydrochloride

This classification denotes an antidepressant agent with the molecular formula C20H26N2O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H9NV66W0I, chemically known as n-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4-dimethoxybenzamide monohydrochloride but more generally known as itopride hydrochloride, which bears US NIH Compound Identifier 129791. European Medicines Agency schedules Itopride hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16440MIG.

UNSPSC 51292207 Itopride hydrochloride is a Commodity code that, based on recent state and local activity, does not align with the work actually being solicited. The sole recent opportunity tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—bears no relation to itopride hydrochloride, a medication used in gastroenterology. The mismatch suggests a tagging error rather than genuine procurement activity under the code's nominal scope. State and local governments do not appear to be buying itopride hydrochloride through public contracts at this time.

The Seminole County opportunity (IFB 60459723LAS, due July 26, 2023) is the only recent record associated with this code, and it documents a different product category entirely—naloxone and drug deactivation systems for community health initiatives. This single, unrelated posting does not establish a procurement pattern or market signal under the itopride hydrochloride Commodity code. Firms evaluating this code should skip pursuit unless additional, properly tagged opportunities emerge to indicate genuine state and local demand for the actual product.